Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.
Clinical trial NCT01232283 · COMPLETED
Trial details
- NCT number
- NCT01232283
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-22
- Primary completion
- 2012-03-15
- Enrollment
- 413
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.